• THIRD ANNUAL EMERGING PHARMA LEADERSHIP AWARDS The editorial event of the season. Pharm Exec profiles the industry’s up-and-coming leaders, who share their insights on what it will take to guide pharma through its next phase. Find out who has the skill, determination, and creativity to take the pharmaceutical industry to the next level.

• COMPANY PROFILE: NICOX
This culturally diverse European start-up has a promising cardiovascular product pipeline that could vault the company toward the top league of emerging biotechs. Editor-in-Chief Bill Looney profiles NiCox’s present status and its hopes for future glory.

• LEGAL/STRATEGY
The recent court decision to overturn two patents on breast-cancer genes is roiling the biotech industry, but that’s only the headliner in the fast-changing world of patent protection. Senior Editor Walter Armstrong details the growing threat to pharma patents.

• E-MARKETING
Richard Malcolm, CEO of patient recruitment firm Acurian, offers insight on the recruitment of clinical trial patients through social media networking—from logistics to potential pitfalls.

• DIRECT TO PATIENT
Lynn O’Connor Vos, CEO of Grey Healthcare Group, maintains that pharma companies should make a stronger push for mobile marketing and compliance techniques, rather than purely focusing on the Internet as the new advertising/compliance medium. The technology is there. Now, how do you harness it?

• DIRECT TO CONSUMER
Guy Mastrion, Chief Global Creative Officer of ad agency Palio, has long kept an eye on the changing landscape of DTP advertising. He’s focusing on using new strategies like augmented reality to increase patient compliance and generalized patient knowledge.

Bonus Distribution:
DIA Annual Meeting
Pharmaceutical Meetings Golf Outing